...you're in the middle of it
The Department of Hematology and Oncology at the Goethe University Hospital Frankfurt offers the full spectrum of blood and cancer diagnostics and therapy. The DFG Emmy-Noether research group of Dr. Sebastian Scheich is part of the Frankfurt Cancer Institute (FCI, https://fci.health) and focuses on aggressive lymphoma biology and signaling. The lab is furthermore funded by grants from philantropy and several governmental organizations, is embedded in a vibrant research environment within the FCI and maintains lively international collaborations. We apply cutting-edge technologies including genome-wide CRISPR/Cas9 screens, quantitative functional proteomics and super resolution microscopy (dSTORM, single molecule tracking, SIM) to dissect oncogenic signaling pathways, study therapy resistance mechanisms and to find novel therapeutic vulnerabilities. We are looking for a highly motivated postdoctoral researcher to join our team.
The position is limited to three years.
Your Role:
- Design, execute, and interpret genome-scale CRISPR/Cas9 screens and functional proteomic approaches, including comprehensive profiling of post-translational modifications
- Application and further development of basic and advanced molecular techniques, including advanced cloning, tissue culture, flow cytometry, and protein expression analysis
- Intellectual contribution to project direction, complex data analysis, interpretation, and dissemination of results
- High degree of scientific independence, including strategic experimental planning, execution, data analysis, and integration of multi-modal datasets within the field of lymphoma research




